196 related articles for article (PubMed ID: 6172641)
1. [Effect of angiotensin II on indices of the fibrinolysis system in experiments in vitro].
Golubenkova NI
Lab Delo; 1981; (12):720-2. PubMed ID: 6172641
[No Abstract] [Full Text] [Related]
2. [Effect of the enzyme preparation longolytin on fibrinolysis in animals].
Serebriakova TN; Andreenko GV; Tsymanovich SG; Maksimova RA; Sharkova TS
Nauchnye Doki Vyss Shkoly Biol Nauki; 1985; (2):66-71. PubMed ID: 3157406
[TBL] [Abstract][Full Text] [Related]
3. [Analytical methods of study of the system of fibrinolysis (plasminogen proactivators-activators, plasminogen-plasmin, antiplasmins, antiactivators) (literature review)].
Guseĭnov ChS; Golovastova GI; Gorelova AM; Cherenkova GM; Mikhailova ND
Lab Delo; 1976; (5):276-83. PubMed ID: 62085
[No Abstract] [Full Text] [Related]
4. [Additional potentials of a method of standard fibrin plates].
Kovalenko AN
Lab Delo; 1980; (10):615-8. PubMed ID: 6158612
[No Abstract] [Full Text] [Related]
5. [Fibrinolysis].
Levy G; Michault A; Jamet M
Ann Anesthesiol Fr; 1978; 19(8):703-8. PubMed ID: 31114
[TBL] [Abstract][Full Text] [Related]
6. [Changes in the content of finbrinolysis activating and inhibiting factors and of fibrinogen in patients with thrombosis and prethrombotic conditions].
Andreenko GV
Folia Haematol Int Mag Klin Morphol Blutforsch; 1975; 102(2):195-7. PubMed ID: 50983
[No Abstract] [Full Text] [Related]
7. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
[TBL] [Abstract][Full Text] [Related]
8. [Fibrinolytic activity of the renal glomerulus. Preliminary results of a histochemical study of plasminogen activity in 44 renal biopsies].
Arrigo G; Baroni M; Benuzzi S; Bellini A; Chiesa I; Colasanti G; D'Amico G
Minerva Nefrol; 1979; 26(4):459-62. PubMed ID: 161611
[No Abstract] [Full Text] [Related]
9. [Various fibrinolytic and coagulation characteristics of the blood plasma after contact with N-amyl alcohol].
Lussa A; Tymińska-Brzósko R
Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1979; 24():91-104. PubMed ID: 161647
[No Abstract] [Full Text] [Related]
10. [Effect of a single administration of plasminogen tissue activator on the state of the fibrinolytic system of rat blood].
Andreenko GV; Shimonaeva EE; Liutova LV; Serebriakova TN
Vopr Med Khim; 1981; 27(1):77-80. PubMed ID: 7193381
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of action of the thrombolytic agents.
Weitz JI
Baillieres Clin Haematol; 1990 Jul; 3(3):583-99. PubMed ID: 2148696
[No Abstract] [Full Text] [Related]
12. [Diagnosis and therapy of consumption coagulopathy].
Lechner K
Wien Klin Wochenschr; 1973 Jun; 85(26):467-70. PubMed ID: 4268703
[No Abstract] [Full Text] [Related]
13. Inherited fibrinolytic disorder due to an enhanced plasminogen activator level.
Aznar J; Estellés A; Vila V; Regañón E; España F; Villa P
Thromb Haemost; 1984 Oct; 52(2):196-200. PubMed ID: 6543037
[TBL] [Abstract][Full Text] [Related]
14. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN
Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
[TBL] [Abstract][Full Text] [Related]
15. Antiplasmins.
Norman PS
Fed Proc; 1966; 25(1):63-7. PubMed ID: 4143744
[No Abstract] [Full Text] [Related]
16. [Assay of fibrinolytic factors with plasminogen-free bovine fibrin-agar-plate and its clinical application. I. Some properties of plate and features for estimation of fibrinolytic factors (author's transl)].
Abe T; Kazama M; Satoh A; Suzuki J; Yamamoto S
Rinsho Ketsueki; 1975 Oct; 16(10):946-52. PubMed ID: 128644
[No Abstract] [Full Text] [Related]
17. [Possibilities of the method of fibrin plates for determination of the activity of the blood fibrinolytic system components].
Butorov VN; Bokarev IN
Lab Delo; 1978; (5):271-3. PubMed ID: 79009
[No Abstract] [Full Text] [Related]
18. Fibrinolytic therapy: biochemical mechanisms.
Robbins KC
Semin Thromb Hemost; 1991 Jan; 17(1):1-6. PubMed ID: 1828622
[No Abstract] [Full Text] [Related]
19. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
Wu JH; Diamond SL
Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
[TBL] [Abstract][Full Text] [Related]
20. [Behavior of some indices of fibrinolysis (fibrinogen, FDP, plasminogen) in mature diabetics].
Di Cesare E; Quartarone M; Cucinotta D; Coppolino E; Squadrito G
Minerva Med; 1979 May; 70(22):1597-9. PubMed ID: 450299
[No Abstract] [Full Text] [Related]
[Next] [New Search]
